Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,140 JPY
Change Today -8.00 / -0.70%
Volume 734.9K
8086 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
As of 2:00 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by NIPRO CORP (8086) in the last 6 months

Announced 01/26/15
Unitika Ltd., Medical Business
Merger/Acquisition

Nipro Corporation (TSE:8086) signed a contract to acquire medical business from Unitika Ltd. (TSE:3103) on January 26, 2015. Unitika aims to concentrate on the growth of its management resources. The medical business reported sales of ¥1.4 billion and operating profit of ¥88 million for the period ending March 2014. About 90 employees working at the Okazaki Plant (Okazaki-shi, Aichi) will be transferred to Nipro. The deal has been resolved by the Board of Unitika. The ...
Read More


8086's price was unchanged after the transaction was announced on 01/26/15.
Investor / Buyer
Nipro Corporation
Creditor / Lender
Unitika Ltd.
 
Announced 12/3/14
2.00B for DONGDUK MEDICAL Corporation
Private Placement

Dongduk Medical Corporation announced that it will receive KRW 2 billion in an equity round of funding from new investor, Nipro Corporation on December 3, 2014. The transaction is by way of third party capital increase in the company. As part of the transaction, the investor will acquire 33.33% stake in the company. On closing of the investment, the name of the company will change to Nipro Dongduk Medical Corporation.


8086's price was unchanged after the transaction was announced on 12/3/14.
Investor / Buyer
Nipro Corporation
 
Announced 11/21/14
205.00M for Cell Science & Technology Institute, Inc.
Merger/Acquisition

Nipro Corporation (TSE:8086) agreed to acquire the remaining 48.33% stake in Cell Science & Technology Institute, Inc. from MEDINET Co., Ltd. (TSE:2370), Funakoshi Co.,Ltd. and Takeshi Sato for approximately ¥210 million on November 21, 2014. For every 90 shares of NIPRO Corp will swap one share of Cell Science & Technology Institute, Inc. Nipro will furnish 0.21 million common shares (tentative) for the share exchange. The shares to be allocated will be held treasury ...
Read More


8086's price was unchanged after the transaction was announced on 11/21/14.
Investor / Buyer
Nipro Corporation
Creditor / Lender
Funakoshi Corporation
MEDINET Co., Ltd.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8086:JP ¥1,140.00 JPY -8.00

8086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,395 INR +84.80
Fuso Pharmaceutical Industries Ltd ¥310.00 JPY -1.00
JMS Co Ltd ¥297.00 JPY 0.00
Nikkiso Co Ltd ¥1,102 JPY -19.00
NxStage Medical Inc $18.27 USD -0.06
View Industry Companies
 

Industry Analysis

8086

Industry Average

Valuation 8086 Industry Range
Price/Earnings 14.9x
Price/Sales 0.5x
Price/Book 1.2x
Price/Cash Flow 15.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIPRO CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.